Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH

World Journal of Hepatology

Volumn 5, Issue 10, 2013, Pages 558-567

  Laggai, Stephan ^a   Simon, Yvette ^a   Ranssweiler, Theo ^a   Kiemer, Alexandra K ^a   Kessler, Sonja M ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

IMP2 IGF2BP2; Methionine choline deficient diet; Neutral lipids; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; p62; Phosphatidylcholine phosphatidylethanolamine ratio; Polar lipids; Thin layer chromatography; Triglycerides

Indexed keywords

EID: 84887323587     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v5.i10.558     Document Type: Article

References (50)

1. Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, Younossi ZM. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009; 7: 234-238 [PMID: 19049831 DOI: 10.1016/j.cgh.2008.11.005]
2. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664-669 [PMID: 10051466 DOI: 10.1002/hep.510290347]
3. Agopian VG, Kaldas FM, Hong JC, Whittaker M, Holt C, Rana A, Zarrinpar A, Petrowsky H, Farmer D, Yersiz H, Xia V, Hiatt JR, Busuttil RW. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg 2012; 256: 624-633 [PMID: 22964732 DOI: 10.1097/SLA.0b013e31826b4b7e]
4. Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V, Tordjman J, Clement K. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 2012; 56: 1751-1759 [PMID: 22707395 DOI: 10.1002/hep.25889]
5. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321 [PMID: 15915461 DOI: 10.1002/hep.20701]
6. Wasmuth HE, Zaldivar MM, Beraza N, Trautwein C. Of mice and NASH - from fat to inflammation and fibrosis. Drug Discov Today Dis Models 2007; 4: 25 [DOI: 10.1016/j.ddmod.2007.09.006]
7. Park HS, Jeon BH, Woo SH, Leem J, Jang JE, Cho MS, Park IS, Lee KU, Koh EH. Time-dependent changes in lipid metabolism in mice with methionine choline deficiencyinduced fatty liver disease. Mol Cells 2011; 32: 571-577 [PMID: 22083307 DOI: 10.1007/s10059-011-0184-6]
8. Lee JY, Moon JH, Park JS, Lee BW, Kang ES, Ahn CW, Lee HC, Cha BS. Dietary oleate has beneficial effects on every step of non-alcoholic Fatty liver disease progression in a methionine- and choline-deficient diet-fed animal model. Diabetes Metab J 2011; 35: 489-496 [PMID: 22111040 DOI: 10.4093/dmj.2011.35.5.489]
9. Rinella ME, Elias MS, Smolak RR, Fu T, Borensztajn J, Green RM. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res 2008; 49: 1068-1076 [PMID: 18227531 DOI: 10.1194/jlr. M800042-JLR200]
10. Tybl E, Shi FD, Kessler SM, Tierling S, Walter J, Bohle RM, Wieland S, Zhang J, Tan EM, Kiemer AK. Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype. J Hepatol 2011; 54: 994-1001 [PMID: 21145819 DOI: 10.1016/j.jhep.2010.08.034]
11. Zhang JY, Chan EK, Peng XX, Tan EM. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med 1999; 189: 1101-1110 [PMID: 10190901 DOI: 10.1084/jem.189.7.1101]
12. Kessler SM, Pokorny J, Zimmer V, Laggai S, Lammert F, Bohle RM, Kiemer AK. IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling. Am J Physiol Gastrointest Liver Physiol 2013; 304: G328-G336 [PMID: 23257922 DOI: 10.1152/ajpgi.00005.2012]
13. Simon Y, Kessler SM, Bohle RM, Haybaeck J, Kiemer AK. The insulin-like growth factor 2 (IGF2) mRNA binding protein p62/IGF2BP2-2 as a promoter of NAFLD and HCC? Gut 2013; In press [DOI: 10.1136/gutjnl-2013-305736]
14. Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 2012; 56: 1384-1391 [PMID: 22326465 DOI: 10.1016/j.jhep.2011.10.027]
15. Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK, Contos MJ, Sterling RK, Fuchs M, Zhou H, Watkins SM, Sanyal AJ. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 2009; 50: 1827-1838 [PMID: 19937697 DOI: 10.1002/hep.23229]
16. Alkhouri N, Dixon LJ, Feldstein AE. Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal. Expert Rev Gastroenterol Hepatol 2009; 3: 445-451 [PMID: 19673631 DOI: 10.1586/egh.09.32]
17. Ricchi M, Odoardi MR, Carulli L, Anzivino C, Ballestri S, Pinetti A, Fantoni LI, Marra F, Bertolotti M, Banni S, Lonardo A, Carulli N, Loria P. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J Gastroenterol Hepatol 2009; 24: 830-840 [PMID: 19207680 DOI: 10.1111/j.1440-1746.2008.05733.x]
18. Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, Sargeant C, Contos MJ, Sanyal AJ. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007;46: 1081-1090 [PMID: 17654743 DOI: 10.1002/hep.21763]
19. Zhang F, Du G. Dysregulated lipid metabolism in cancer. World J Biol Chem 2012; 3: 167-174 [PMID: 22937213 DOI: 10.4331/wjbc.v3.i8.167]
20. Lonardo A, Loria P. Potential for statins in the chemoprevention and management of hepatocellular carcinoma. J Gastroenterol Hepatol 2012; 27: 1654-1664 [PMID: 22849701 DOI: 10.1111/j.1440-1746.2012.07232.x]
21. Muir K, Hazim A, He Y, Peyressatre M, Kim DY, Song X, Beretta L. Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. Cancer Res 2013; 73: 4722-4731 [PMID: 23749645 DOI: 10.1158/0008-5472.CAN-12-3797]
22. Fuchs B, Süss R, Teuber K, Eibisch M, Schiller J. Lipid analysis by thin-layer chromatography--a review of the current state. J Chromatogr A 2011; 1218: 2754-2774 [PMID: 21167493 DOI: 10.1016/j.chroma.2010.11.066]
23. Kramer JKG, Fouchard RC, Farnworth ER. A complete separation of lipids by three-directional thin layer chromatography. Lipids 1983; 18: 896-899 [DOI: 10.1007/BF02534569]
24. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lübbert H, Bujard H. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 10933-10938 [PMID: 8855286 DOI: 10.1073/pnas.93.20.10933]
25. Hara A, Radin NS. Lipid extraction of tissues with a lowtoxicity solvent. Anal Biochem 1978; 90: 420-426 [PMID: 727482 DOI: 10.1016/0003-2697(78)90046-5]
26. Pai JK, Siegel MI, Egan RW, Billah MM. Phospholipase D catalyzes phospholipid metabolism in chemotactic peptidestimulated HL-60 granulocytes. J Biol Chem 1988; 263: 12472-12477 [PMID: 3165977]
27. Plekhanov AY. Rapid staining of lipids on thin-layer chromatograms with amido black 10B and other water-soluble stains. Anal Biochem 1999; 271: 186-187 [PMID: 10419634 DOI: 10.1006/abio.1999.4127S0003-2697(99)94127-1]
28. Schuh TJ. An Introduction to Lipid Analysis in the Cell Biology Laboratory. The Am Biol Teach 2002; 64: 122
29. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9: 671-675 [PMID: 22930834 DOI: 10.1038/nmeth.2089]
30. Larter CZ, Yeh MM, Haigh WG, Williams J, Brown S, Bell-Anderson KS, Lee SP, Farrell GC. Hepatic free fatty acids accumulate in experimental steatohepatitis: role of adaptive pathways. J Hepatol 2008; 48: 638-647 [PMID: 18280001 DOI: 10.1016/j.jhep.2007.12.011]
31. Miura K, Ohnishi H. Nonalcoholic fatty liver disease: from lipid profile to treatment. Clin J Gastroenterol 2012; 5: 313-321 [DOI: 10.1007/s12328-012-0315-4]
32. Kurantz MJ, Maxwell RJ, Kwoczak R, Taylor F. Rapid and sensitive method for the quantitation of non-polar lipids by high-performance thin-layer chromatography and fluorodensitometry. J Chromatogr A 1991; 549: 387 [DOI: 10.1016/S0021-9673(00)91449-3]
33. Hijona E, Hijona L, Larzabal M, Sarasqueta C, Aldazabal P, Arenas J, Bujanda L. Biochemical determination of lipid content in hepatic steatosis by the Soxtec method. World J Gastroenterol 2010; 16: 1495-1499 [PMID: 20333790 DOI: 10.3748/wjg.v16.i12.1495]
34. Hidiroglou N, McDowell LR, Johnson DD. Effect of diet on animal performance, lipid composition of subcutaneous adipose and liver tissue of beef cattle. Meat Sci 1987; 20: 195-210 [PMID: 22054497 DOI: 10.1016/0309-1740(87)90011-8]
35. Dawson RM, Hemington N, Davenport JB. Improvements in the method of determining individual phospholipids in a complex mixture by successive chemical hydrolyses. Biochem J 1962; 84: 497-501 [PMID: 13884048]
36. Fiori M, Scintu M, Addis M. Characterization of the Lipid Fraction in Lamb Meat: Comparison of Different Lipid Extraction Methods. Food Anal Methods 2013: 1-9
37. Jiang S, Nail SL. Effect of process conditions on recovery of protein activity after freezing and freeze-drying. Eur J Pharm Biopharm 1998; 45: 249-257 [PMID: 9653629 DOI: 10.1016/S0939-6411(98)00007-1]
38. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000; 105: 1067-1075 [PMID: 10772651 DOI: 10.1172/JCI8814]
39. Yao ZM, Vance DE. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem 1988; 263: 2998-3004 [PMID: 3343237]
40. Sundler R, Akesson B. Biosynthesis of phosphatidylethanolamines and phosphatidylcholines from ethanolamine and choline in rat liver. Biochem J 1975; 146: 309-315 [PMID: 168873]
41. Caballero F, Fernández A, Matías N, Martínez L, Fucho R, Elena M, Caballeria J, Morales A, Fernández-Checa JC, García-Ruiz C. Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione. J Biol Chem 2010; 285: 18528-18536 [PMID: 20395294 DOI: 10.1074/jbc. M109.099333]
42. Chao W, D'Amore PA. IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev 2008; 19: 111-120 [PMID: 18308616 DOI: 10.1016/j.cytogfr.2008.01.005]
43. Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 2007; 45: 1366-1374 [PMID: 17476695 DOI: 10.1002/hep.21655]
44. Yetukuri L, Katajamaa M, Medina-Gomez G, Seppänen-Laakso T, Vidal-Puig A, Oresic M. Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis. BMC Syst Biol 2007; 1: 12 [PMID: 17408502 DOI: 10.1186/1752-0509-1-12]
45. Gorden DL, Ivanova PT, Myers DS, McIntyre JO, VanSaun MN, Wright JK, Matrisian LM, Brown HA. Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model. PLoS One 2011; 6: e22775 [PMID: 21857953 DOI: 10.1371/journal.pone.0022775]
46. Rappley I, Myers DS, Milne SB, Ivanova PT, Lavoie MJ, Brown HA, Selkoe DJ. Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with alpha-synuclein genotype. J Neurochem 2009; 111: 15-25 [PMID: 19627450 DOI: 10.1111/j.1471-4159.2009.06290.x]
47. Tabas I. Cholesterol and phospholipid metabolism in macrophages. Biochim Biophys Acta 2000; 1529: 164-174 [PMID: 11111086 DOI: 10.1016/S1388-1981(00)00146-3]
48. Li Z, Agellon LB, Allen TM, Umeda M, Jewell L, Mason A, Vance DE. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab 2006; 3: 321-331 [PMID: 16679290 DOI: 10.1016/j.cmet.2006.03.007]
49. Yao PM, Tabas I. Free cholesterol loading of macrophages induces apoptosis involving the fas pathway. J Biol Chem 2000; 275: 23807-23813 [PMID: 10791964 DOI: 10.1074/jbc. M002087200]
50. Arora AS, Jones BJ, Patel TC, Bronk SF, Gores GJ. Ceramide induces hepatocyte cell death through disruption of mitochondrial function in the rat. Hepatology 1997; 25: 958-963 [PMID: 9096604 DOI: 10.1002/hep.510250428]